Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China
· Delayed Price · Currency is CNY 25.74
+0.06 (0.23%)
Apr 29, 2026, 3:04 PM CST
SHE:002880 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 5,838 | 5,783 | 6,126 | 7,967 | 7,233 | 7,298 | Upgrade
|
| Market Cap Growth | -4.63% | -5.59% | -23.11% | 10.16% | -0.90% | -6.20% | Upgrade
|
| Enterprise Value | 6,607 | 6,423 | 6,434 | 8,271 | 7,256 | 7,063 | Upgrade
|
| Last Close Price | 25.74 | 25.50 | 26.83 | 34.64 | 31.27 | 31.31 | Upgrade
|
| PE Ratio | 25.00 | 23.48 | 24.16 | 36.44 | 61.55 | 35.53 | Upgrade
|
| Forward PE | - | 21.43 | 22.23 | 17.21 | 17.21 | 18.82 | Upgrade
|
| PS Ratio | 4.62 | 4.57 | 5.09 | 7.60 | 10.83 | 8.04 | Upgrade
|
| PB Ratio | 2.36 | 2.37 | 2.73 | 3.90 | 3.87 | 4.08 | Upgrade
|
| P/TBV Ratio | 2.57 | 2.58 | 2.98 | 4.29 | 4.14 | 4.36 | Upgrade
|
| P/FCF Ratio | - | 61.86 | - | 115.33 | - | 1204.41 | Upgrade
|
| P/OCF Ratio | 46.94 | 21.98 | 34.46 | 20.02 | 6032.03 | 29.56 | Upgrade
|
| EV/Sales Ratio | 5.23 | 5.07 | 5.35 | 7.89 | 10.86 | 7.78 | Upgrade
|
| EV/EBITDA Ratio | 13.77 | 13.46 | 14.64 | 25.20 | 40.17 | 25.15 | Upgrade
|
| EV/EBIT Ratio | 21.01 | 19.82 | 19.87 | 34.19 | 62.32 | 31.20 | Upgrade
|
| EV/FCF Ratio | -165.51 | 68.70 | - | 119.73 | - | 1165.53 | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.34 | 0.31 | 0.26 | 0.29 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 1.70 | 1.75 | 1.58 | 1.63 | 3.01 | 0.15 | Upgrade
|
| Debt / FCF Ratio | - | 8.97 | - | 7.77 | - | 7.17 | Upgrade
|
| Net Debt / Equity Ratio | 0.30 | 0.19 | 0.12 | 0.13 | 0.14 | -0.16 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.54 | 0.98 | 0.61 | 0.80 | 1.40 | -1.03 | Upgrade
|
| Net Debt / FCF Ratio | -18.46 | 5.01 | -3.46 | 3.80 | -0.77 | -47.64 | Upgrade
|
| Asset Turnover | 0.36 | 0.36 | 0.39 | 0.39 | 0.29 | 0.47 | Upgrade
|
| Inventory Turnover | 0.86 | 0.92 | 0.95 | 0.96 | 0.83 | 1.33 | Upgrade
|
| Quick Ratio | 0.82 | 1.12 | 1.73 | 1.55 | 2.21 | 3.22 | Upgrade
|
| Current Ratio | 2.36 | 2.37 | 3.61 | 4.15 | 4.93 | 5.98 | Upgrade
|
| Return on Equity (ROE) | 9.78% | 10.48% | 11.84% | 11.12% | 6.63% | 12.02% | Upgrade
|
| Return on Assets (ROA) | 5.65% | 5.75% | 6.55% | 5.55% | 3.18% | 7.37% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.88% | 10.37% | 11.49% | 9.68% | 5.68% | 14.08% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.30% | 10.70% | 11.30% | 9.30% | 5.00% | 12.30% | Upgrade
|
| Earnings Yield | 4.00% | 4.26% | 4.14% | 2.74% | 1.63% | 2.81% | Upgrade
|
| FCF Yield | -0.68% | 1.62% | -1.27% | 0.87% | -4.51% | 0.08% | Upgrade
|
| Dividend Yield | 0.78% | - | 0.75% | 1.16% | - | 0.64% | Upgrade
|
| Payout Ratio | 27.58% | 26.68% | 25.99% | 30.00% | 49.09% | 20.36% | Upgrade
|
| Buyback Yield / Dilution | -0.00% | 0.00% | -0.00% | -0.01% | 0.01% | -0.00% | Upgrade
|
| Total Shareholder Return | 0.77% | 0.00% | 0.74% | 1.15% | 0.01% | 0.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.